Fortress Biotech Inc

FBIONASDAQ · USD
1.90USD0.00 (+7.35%)
955

Fortress Biotech Inc (FBIO) Unusual Options Activity Today

FBIO's highest volume power reading is 0.38%, on the $2.5 PUT expiring Dec 18, 2026. This strike traded 2 contracts against just 521 in open interest. On the call side, the highest reading is the $2.5 CALL expiring Dec 18, 2026 at 0.25%, with 2 contracts traded against 795 open, as of Nov 20, 2026.

Read more

Checking FBIO unusual options activity helps you spot when traders are making outsized bets on Fortress Biotech Inc before the broader market catches on. Unusual activity flags contracts trading at multiples of their average daily volume, often signaling informed money positioning ahead of a catalyst. Use our scanner to monitor FBIO unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically means volume vastly exceeds open interest at a given strike, or total contract volume on a name spikes well above its norm. Watching FBIO unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking FBIO unusual options volume across calls and puts helps you separate hedging from genuinely speculative positioning, especially valuable around earnings, product launches, and macro events.

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children.

2026-12-18
Calls
2.50—0.050.0599%27950.25%
5.00—0.100.10270%0580.00%
7.50—3.803.801,000%010.00%
Puts
2.500.500.800.65104%25210.38%
5.001.255.503.38382%00—
7.503.207.905.5553%00—

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →